Research design and methods The cohort of 9690 diabetic individuals in England, followed for 2 years. The algorithms calculated individual risk for development of preproliferative retinopathy (R2), ...

Approval of Susvimo marks the first continuous delivery therapy indicated for diabetic retinopathy. The FDA has approved Roche’s Susvimo (ranibizumab injection) 100 mg/mL for treating patients with ...

Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only one treatment every nine months – – Susvimo’s innovative ...

A team of ophthalmology researchers at Stanford University, working with a colleague from New York University School of Medicine, has found that despite promise for detecting diabetic retinopathy ...

Perspective from David A. Eichenbaum, MD The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech. The approval was supported by positive 1 ...

Background: This study was performed to assess the prevalence of dry eye syndrome and diabetic retinopathy (DR) in type 2 diabetic patients and their contributing factors. Methods: 199 type 2 ...

Although it looks like a smaller version of the R1S, the R2 is its own unique vehicle. It's built on a new, distinct platform that uses different battery cells and construction methods.

Less than a week after sending a beautifully wrapped fleet of R2 validation prototypes out into the wild, Rivian founder and CEO has shared more of the design work at HQ, including a look at the ...

Rivian founder and CEO RJ Scaringe has posted another interesting facet into the design of the American automaker’s upcoming R2 BEVs. As you’ll see below, the Rivian R2’s body harness has ...

June 12, 2025 — Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that targets four gut hormones instead of the usual one to ...